His scientific interests lie mostly in Amyloid, Biochemistry, Monomer, Oligomer and Protein oligomerization. Gal Bitan interconnects Neurotoxicity, Neurodegeneration, Stereochemistry, Alzheimer's disease and In vivo in the investigation of issues within Amyloid. His Neurodegeneration research includes elements of P3 peptide, Amyotrophic lateral sclerosis, Dementia and Neuroscience.
His work on Fibril as part of general Biochemistry research is often related to Extramural, thus linking different fields of science. Gal Bitan focuses mostly in the field of Protein oligomerization, narrowing it down to matters related to Random hexamer and, in some cases, Circular dichroism. His studies deal with areas such as Amyloid beta and Peptide as well as Biophysics.
His primary scientific interests are in Amyloid, Biochemistry, Biophysics, Stereochemistry and Peptide. Gal Bitan combines subjects such as Neurotoxicity, P3 peptide, Neurodegeneration and In vivo with his study of Amyloid. His Neurodegeneration research is multidisciplinary, relying on both Amyotrophic lateral sclerosis and Neuroscience.
Gal Bitan has researched Biochemistry in several fields, including Biochemistry of Alzheimer's disease and Toxicity. His work on Fibril as part of general Biophysics research is frequently linked to Monomer, thereby connecting diverse disciplines of science. The various areas that Gal Bitan examines in his Peptide study include Protein structure and C-terminus.
Gal Bitan mainly focuses on Biophysics, Fibril, In vitro, Molecular tweezers and Amyloid. His studies in Biophysics integrate themes in fields like Peptide, Tau protein, Peptide binding and Binding site. His Fibril research incorporates elements of Extracellular and Intracellular.
His In vitro research focuses on In vivo and how it connects with Pharmacology, Amyotrophic lateral sclerosis, Microgliosis, Tauopathy and Presenilin. The Molecular tweezers study combines topics in areas such as Viability assay, Neurotoxicity, Lead compound and Lysine. The study incorporates disciplines such as Transthyretin, Endocrinology and Neurodegeneration in addition to Amyloid.
His primary areas of study are Synucleinopathies, Extracellular, Fibril, Computational biology and Microvesicles. His work in Synucleinopathies addresses issues such as Atrophy, which are connected to fields such as Cancer research and Neuropathology. He has included themes like Priming, Amyloid beta, Intracellular and Pathogenesis in his Extracellular study.
His research in Fibril intersects with topics in Long-term potentiation, In vitro, Kinase and Phosphorylation. His Kinase research is multidisciplinary, incorporating perspectives in Biophysics, Tau protein and Binding site. His Autophagy research spans across into areas like Amyloid and Neurodegeneration.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.
Gal Bitan;Marina D. Kirkitadze;Aleksey Lomakin;Sabrina S. Vollers.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease
Summer L. Bernstein;Nicholas F. Dupuis;Noel D. Lazo;Thomas Wyttenbach.
Nature Chemistry (2009)
Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
Marina D. Kirkitadze;Gal Bitan;Gal Bitan;David B. Teplow;David B. Teplow.
Journal of Neuroscience Research (2002)
Amyloid β-Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS
Gal Bitan;Aleksey Lomakin;David B. Teplow.
Journal of Biological Chemistry (2001)
In silico study of amyloid β-protein folding and oligomerization
B. Urbanc;L. Cruz;S. Yun;S. V. Buldyrev.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Amyloid β-protein: Monomer structure and early aggregation states of Aβ42 and its Pro19 alloform
Summer L Bernstein;Thomas Wyttenbach;Andrij Baumketner;Joan-Emma Shea.
Journal of the American Chemical Society (2005)
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
Alon Monsonego;Victor Zota;Arnon Karni;Jeffery I. Krieger.
Journal of Clinical Investigation (2003)
Elucidation of Primary Structure Elements Controlling Early Amyloid β-Protein Oligomerization
Gal Bitan;Sabrina S. Vollers;David B. Teplow.
Journal of Biological Chemistry (2003)
Amyloid beta-protein monomer structure: a computational and experimental study.
Andrij Baumketner;Summer L. Bernstein;Thomas Wyttenbach;Gal Bitan.
Protein Science (2006)
Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid Proteins
Sharmistha Sinha;Dahabada H. J. Lopes;Zhenming Du;Eric S. Pang.
Journal of the American Chemical Society (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: